Reported success rates of the different surgical options to treat periprosthetic infection vary in the literature. However, these rates rely on how authors define success. The goal of this study was to determine the most commonly used definitions of success based on a classification system published by the Musculoskeletal Infection Society. We found most studies did not use the strictest definitions of success, and success rates decreased when stricter definitions were used. 

This study investigates the ability of a promising new antibiotic, dalbavancin, to be used as an antibiotic incorporated into polymethyl methacrylate (PMMA) cement or other carriers (such as calcium sulfate) to treat bone and joint infections. For antibiotics to be used locally, they must retain their efficacy after heat exposure during PMMA polymerization and at human core body temperature. This study demonstrates that dalbavancin is stable at the temperatures required for local use.